Early Treatment of All Persons with HIV Infection: From Immune Activation and Inflammation Studies to Randomized Clinical Trials
Journal: Journal of HIV and AIDS (Vol.4, No. 2)Publication Date: 2018-04-03
Authors : Jean Cyr Yombi Jean-Christophe Goffard;
Page : 1-11
Keywords : Early treatment; Asymptomatic HIV; CD4+ cell count; Antiretroviral therapy; Human immunodeficiency virus; People living with HIV;
Abstract
Treatment of people living with Human Immunodeficiency Virus (HIV) infection with antiretroviral therapy has dramatically reduced disease progression and death. There are strong supporting data and a public health argument that treatment prevents transmission of the disease. The optimal timing for starting antiretroviral therapy in asymptomatic people living with HIV infection was the subject of debate until 2015, when two large randomized studies (TEMPRANO and START) indisputably showed benefit of treating all people living with HIV regardless of CD4+ cell count. In this paper, we review the evidence from immune activation and inflammation studies to randomized clinical trials that supports early treatment of all asymptomatic people living with HIV regardless of CD4+ cell count, and we describe challenges and perspectives behind this strategy.
Other Latest Articles
- Perceptions and Impact of HIV Stigma among High Risk Populations in the US Deep South
- PRÁCTICAS DE CONTABILIDAD DE GESTIÓN, PARA LA TOMA DE DECISIONES
- Prevalence of Frailty and Association with the Immune Profile Among Older Adults with HIV at a University-Affiliated Hospital
- IMPACTO DE LARGAS HORAS DE TRABAJO EN EL EMPODERAMIENTO SOCIOECONÓMICO DE LAS MUJERES
- HIV and Depression: A Potential Role for Attention Training in Prevention and Treatment
Last modified: 2020-08-10 22:15:53